Fig. 1: Overall survival and event-free survival of R/R B-ALL patients treated with anti-CD19 CAR T therapy.

Pooled data from published Kaplan Meier curves were used to estimate (A) the Overall Survival (OS) of the infused population and (B) the Event-free survival (EFS) of the infused population.